The Pharmaceutical Journal
Vol 274 No 7347 p517
30 April 2005

This article
Reprint   Photocopy

PDF 75K, Acrobat Reader

· Dispensing doctors
· Council election (5)
· GlaxoSmithKline
· Statins
· Salamol
· Supervision
· The Society
· The Journal

Letters to the Editor

GlaxoSmithKline

Ongoing dissatisfaction

From Mr. D. W. M. Davidson, MRPharmS

As chairman of the Association of Independent Multiple Chemists in Scotland, may I record on behalf of our members our ongoing dissatisfaction with GlaxoSmithKline in the way pharmacy in Scotland has been treated. It is obvious in this devolved age that multinationals like GSK are unaware of the different ways devolved areas are negotiating their different strategies to meet their own health objectives. They should assess these different strategies and make their commercial decisions to help provide the best health care for patients and providers where possible and, if not, at least speak and explain their actions before springing it in public.

Small multiples are, on the whole, the most innovative and entrepreneurial area of pharmacy, yet we were never consulted or, it seems, ever considered.

D. W. M. Davidson
Blairgowrie, Perthshire

Send your letter to The Editor

Previous Topic (Council election)
Next Topic (Statins)